Home › Familial Amyloid Neuropathies › Ohio
Familial Amyloid Neuropathies clinical trials in Ohio
4 studies for Familial Amyloid Neuropathies are looking for participants at sites in Ohio.
Cities in Ohio
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Columbus
RecruitingObservational study
All ages · All sexes · Updated Sep 8, 2026 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- Cleveland Clinic, Cleveland
RecruitingObservational study
Ages 30 to 80 · All sexes · Updated Aug 31, 2026 · NCT05489549Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Cleveland Clinic, Cleveland
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.